RxDoctor Payments Data

Donald Mowlds

Plastic Surgery · Newport Beach, CANPI 1336405752

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $9,328 of the $14,144 with a category attached, or 65.9%. It is spread thinly across 19 manufacturers, the largest accounting for just 22.4%. Reporting peaked in 2019 at $5,561 and has fallen 72.9% since, to $1,507 in 2025.

$14,144in general payments, 2019–2025

Across 173 payments — averaging $81.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Acelrx Pharmaceuticals, Inc.$3K
  • Mentor Worldwide LLC$3K
  • Medical Device Business Services, Inc.$2K
  • TELA Bio, Inc.$2K
  • Davol Inc.$1K
  • Integra Lifesciences Corporation$801
  • plus $2K from 13 others
$44,292in research payments, 2019–2025

Across 1 payment — averaging $44,292 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Davol Inc.$44K

What the payments were for

  • Speaking & faculty fees$2,00014%
  • Travel & lodging$2,16515%
  • Food & beverage$9,32866%
  • Other$6525%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,144 in reported general payments places this provider in the 85th percentile of 780 plastic surgery providers in California.

See all plastic surgery providers in California →

Most prescribed under Part D

DrugClaimsCost to plans & patients
Doxycycline Hyclate16$74
Ondansetron Hcl11$49

Paid to pharmacies, not to this prescriber.

Other plastic surgery in Newport Beach

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →